Roopa Mehta

1.8k total citations
47 papers, 1.2k citations indexed

About

Roopa Mehta is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Roopa Mehta has authored 47 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Surgery and 9 papers in Molecular Biology. Recurrent topics in Roopa Mehta's work include Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers), Diabetes Management and Research (10 papers) and Lipoproteins and Cardiovascular Health (7 papers). Roopa Mehta is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers), Diabetes Management and Research (10 papers) and Lipoproteins and Cardiovascular Health (7 papers). Roopa Mehta collaborates with scholars based in Mexico, United States and Brazil. Roopa Mehta's co-authors include Carlos A. Aguilar‐Salinas, Daniel Cuevas‐Ramos, Francisco J. Gómez‐Pérez, Paloma Almeda‐Valdés, Rosalba Rojas, Griselda X. Brito-Córdova, Olimpia Arellano‐Campos, Arsenio Vargas‐Vázquez, Juan Rull and Juan Manuel Malacara and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes Care.

In The Last Decade

Roopa Mehta

44 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roopa Mehta Mexico	19	570	267	260	248	222	47	1.2k
Yu Mi Kang South Korea	23	553 1.0×	273 1.0×	312 1.2×	445 1.8×	178 0.8×	67	1.4k
Jordi Goldstein‐Fuchs United States	5	738 1.3×	182 0.7×	278 1.1×	191 0.8×	233 1.0×	6	1.5k
Ja Young Jeon South Korea	20	498 0.9×	244 0.9×	390 1.5×	233 0.9×	197 0.9×	66	1.2k
Guillermo Cardoso‐Saldaña Mexico	22	455 0.8×	225 0.8×	207 0.8×	318 1.3×	275 1.2×	96	1.5k
Satoshi Iimuro Japan	21	447 0.8×	248 0.9×	370 1.4×	153 0.6×	183 0.8×	34	1.4k
Hisayuki Katsuyama Japan	19	568 1.0×	286 1.1×	407 1.6×	316 1.3×	339 1.5×	70	1.4k
Tomoko Nakagami Japan	18	767 1.3×	174 0.7×	226 0.9×	523 2.1×	154 0.7×	53	1.2k
Fritz Oberhollenzer Austria	8	664 1.2×	267 1.0×	199 0.8×	480 1.9×	135 0.6×	18	1.3k
Jeannette Lee Singapore	21	298 0.5×	192 0.7×	160 0.6×	220 0.9×	137 0.6×	33	1.2k
Srividya Kidambi United States	20	378 0.7×	234 0.9×	188 0.7×	166 0.7×	279 1.3×	37	1.1k

Countries citing papers authored by Roopa Mehta

Since Specialization

Citations

This map shows the geographic impact of Roopa Mehta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roopa Mehta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roopa Mehta more than expected).

Fields of papers citing papers by Roopa Mehta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roopa Mehta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roopa Mehta. The network helps show where Roopa Mehta may publish in the future.

Co-authorship network of co-authors of Roopa Mehta

This figure shows the co-authorship network connecting the top 25 collaborators of Roopa Mehta. A scholar is included among the top collaborators of Roopa Mehta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roopa Mehta. Roopa Mehta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

James, Steven, Roopa Mehta, O.F.W. James, et al.. (2025). The status of care for youth with type 1 diabetes within and coming from humanitarian crises settings: a narrative review. Conflict and Health. 19(1). 2–2.

Cruz‐Bautista, Ivette, Daniel Elías-López, Arsenio Vargas‐Vázquez, et al.. (2025). Lipoprotein (a) levels and clinical decision-making: data from a Mexican cohort at a tertiary medical institution. Lipids in Health and Disease. 24(1). 192–192.

Home, Philip, et al.. (2025). Efficacy and safety of iGlarLixi versus IDegAsp in people with type 2 diabetes inadequately controlled with basal insulin: A systematic literature review and network meta‐analysis of non‐Asian studies. Diabetes Obesity and Metabolism. 27(6). 3410–3418.

Ogungbe, Oluwabunmi, Sonia Y. Angell, Lawrence J. Appel, et al.. (2024). Disruption of diabetes and hypertension care during the COVID-19 pandemic and recovery approaches in the Latin America and Caribbean region: a scoping review protocol. BMJ Open. 14(1). e074443–e074443. 2 indexed citations

Mehta, Roopa, Arsenio Vargas‐Vázquez, Neftalí Eduardo Antonio-Villa, et al.. (2024). Evaluation of arterial stiffness in primary atherogenic dyslipidemias. SHILAP Revista de lepidopterología. 11(2). 1 indexed citations

Martagón, Alexandro J., Carlos A. Fermín‐Martínez, Neftalí Eduardo Antonio-Villa, et al.. (2022). Arterial Stiffness and HbA1c: Association Mediated by Insulin Resistance in Hispanic Adults. International Journal of Environmental Research and Public Health. 19(17). 11017–11017. 6 indexed citations

Home, Philip, et al.. (2021). Efficacy and safety of iGlarLixi versus IDegAsp : Results of a systematic literature review and indirect treatment comparison. Diabetes Obesity and Metabolism. 23(12). 2660–2669. 7 indexed citations

Márquez‐Salinas, Alejandro, Carlos A. Fermín‐Martínez, Neftalí Eduardo Antonio-Villa, et al.. (2021). Adaptive Metabolic and Inflammatory Responses Identified Using Accelerated Aging Metrics Are Linked to Adverse Outcomes in Severe SARS-CoV-2 Infection. The Journals of Gerontology Series A. 76(8). e117–e126. 12 indexed citations

Vargas‐Vázquez, Arsenio, Omar Yaxmehen Bello‐Chavolla, Neftalí Eduardo Antonio-Villa, et al.. (2021). Comparative assessment of LDL-C and VLDL-C estimation in familial combined hyperlipidemia using Sampson’s, Martin’s and Friedewald’s equations. Lipids in Health and Disease. 20(1). 46–46. 29 indexed citations

10.

Antonio-Villa, Neftalí Eduardo, et al.. (2020). The combination of insulin resistance and visceral adipose tissue estimation improves the performance of metabolic syndrome as a predictor of type 2 diabetes. Diabetic Medicine. 37(7). 1192–1201. 12 indexed citations

11.

Mehta, Roopa, Pablo Raffaele, Francisco Padilla, et al.. (2020). Latin American Expert Consensus for Comprehensive Management of Type 2 Diabetes from a Metabolic–Cardio–Renal Perspective for the Primary Care Physician. Diabetes Therapy. 12(1). 1–20. 5 indexed citations

12.

Reyes-Muñoz, Enrique, Rosalba Rojas, Fernando Guerrero‐Romero, et al.. (2020). Development and validation of a tool for predicting type 2 diabetes in Mexican women of reproductive age. Endocrinología Diabetes y Nutrición. 67(9). 578–585. 3 indexed citations

13.

Mehta, Roopa, et al.. (2018). Performance of LDL-C calculated with Martin's formula compared to the Friedewald equation in familial combined hyperlipidemia. Atherosclerosis. 277. 204–210. 40 indexed citations

14.

Cruz‐Bautista, Ivette, Roopa Mehta, Javier Cabiedes, et al.. (2014). Determinants of VLDL composition and apo B-containing particles in familial combined hyperlipidemia. Clinica Chimica Acta. 438. 160–165. 18 indexed citations

15.

Almeda‐Valdés, Paloma, Daniel Cuevas‐Ramos, Roopa Mehta, et al.. (2014). Factors associated with postprandial lipemia and apolipoprotein A-V levels in individuals with familial combined hyperlipidemia. BMC Endocrine Disorders. 14(1). 90–90. 12 indexed citations

16.

Mehta, Roopa, et al.. (2011). [Epidemiology of diabetes in the elderly].. PubMed. 62(4). 305–11. 11 indexed citations

17.

Gómez-Sámano, Miguel Ángel, et al.. (2011). Metformin and Improvement of the Hepatic Insulin Resistance Index Independent of Anthropometric Changes. Endocrine Practice. 18(1). 8–16. 9 indexed citations

18.

Garduño‐García, José de Jesús, Roopa Mehta, Olimpia Arellano‐Campos, et al.. (2010). TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. European Journal of Endocrinology. 163(2). 273–278. 220 indexed citations

19.

Aguilar‐Salinas, Carlos A., et al.. (2004). Familial Combined Hyperlipidemia: Controversial Aspects of its Diagnosis and Pathogenesis. Seminars in Vascular Medicine. 4(2). 203–209. 21 indexed citations

20.

Lara‐Esqueda, Agustín, Carlos A. Aguilar‐Salinas, Oscar J Velázquez-Monroy, et al.. (2004). The body mass index is a less-sensitive tool for detecting cases with obesity-associated co-morbidities in short stature subjects. International Journal of Obesity. 28(11). 1443–1450. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact